Hyclone Life Sciences Solutions India Private Limited - Company Profile

It is a life sciences private limited company based in Bangalore, Karnataka, India, established in 2019.
2019 Bangalore, Karnataka, India Active
Last Updated:
About Hyclone Life Sciences Solutions India Private Limited

Hyclone Life Sciences Solutions India Private Limited, a active private limited company, was established on 01 August 2019 in Bangalore, Karnataka, India. Engaging in biotechnology within the professional, scientific and technical sector, it holds CIN: U24304KA2019PTC126720. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹245.00 Cr and a paid-up capital of ₹235.16 Cr.

Employing 496 professional, Its leadership includes Satya Prasad Udandravu (Director), James Benjamin (Director), Ramakrishna Panicker Manoj Kumar (Director). Past directors included Satya Prasad Udandravu, Raghavendra Goud Vaggu, Ganesh Karnatakam. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Galileo, John F Welch Technology Centre, 122 Epip Zone Phase Ii, Hoodi Village, White, Field Road, Bangalore, Karnataka, 560066.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304KA2019PTC126720

  • Registration Number

    126720

  • Incorporation Date

    01 August 2019

  • Authorized Capital

    ₹245.00 Cr

  • Paid-Up Capital

    ₹235.16 Cr

  • ROC Code

    Roc Bangalore

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 245.00 Cr
  • Paid Up Capital ₹ 235.16 Cr
  • Company Age 6 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 2.70%
  • Profit Growth **** -20.38%
  • Ebitda **** -23.88%
  • Net Worth 38.95%
  • Total Assets **** 17.72%
Company report

Hyclone Life Sciences Solutions India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Hyclone Life Sciences Solutions India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Hyclone Life Sciences Solutions India Private Limited?
Current Directors
Name Designation Appointment Date Status
Satya Prasad Udandravu Director 14 Jun 2022 Current
James Benjamin Director 31 Mar 2020 Current
Ramakrishna Panicker Manoj Kumar Director 05 Jun 2024 Current
Amol Laxman Kulkarni Company Secretary 06 Mar 2020 Current
Balasubramanian Narayanan Iyer Director 12 Mar 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 30 Sep 2022 Past
Pramod Abcsdd Director 30 Aug 2022 Past
Pramod Abcsdd Director 14 Jun 2022 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 31 Mar 2020 Past
Pramod Abcsdd Director 31 Mar 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hyclone Life Sciences Solutions India.

Hyclone Life Sciences Solutions India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.7% increase. The company also saw a substantial fall in profitability, with a 20.38% decrease in profit. The company's net worth Soared by an impressive increase of 38.95%.

Hyclone Life Sciences Solutions India revenue growth over time
Hyclone Life Sciences Solutions India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
2.70%
*******
*******
*******
*******
Revenue from Operations
*******
0.22%
*******
*******
*******
*******
Total Assets
*******
17.72%
*******
*******
*******
*******
Profit or Loss
*******
-20.38%
*******
*******
*******
*******
Net Worth
*******
38.95%
*******
*******
*******
*******
EBITDA
*******
-23.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hyclone Life Sciences Solutions India?

In 2023, Hyclone Life Sciences Solutions India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Hyclone Life Sciences Solutions India?

Hyclone Life Sciences Solutions India has a workforce of 496 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Hyclone Life Sciences Solutions India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hyclone Life Sciences Solutions India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hyclone Life Sciences Solutions India
Recent Activity within the Organization
  • Annual General Meeting

    The activity Hyclone Life Sciences Solutions India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Hyclone Life Sciences Solutions India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore. was recorded as a recent event.

  • Director Appointment

    Progress on Balasubramanian Narayanan Iyer was appointed as a Director was appointed as a Director on 12 Mar 2025 & has been associated with this company since 11 months . was documented.

  • Director Appointment

    The activity Ramakrishna Panicker Manoj Kumar was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    The activity Satya Prasad Udandravu was appointed as a Director was appointed as a Director on 14 Jun 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    James Benjamin was appointed as a Director was appointed as a Director on 31 Mar 2020 & has been associated with this company since 5 years 10 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Hyclone Life Sciences Solutions India Private Limited?

The CIN of Hyclone Life Sciences Solutions India Private Limited is U24304KA2019PTC126720.

Where is Hyclone Life Sciences Solutions India Private Limited headquartered?

Hyclone Life Sciences Solutions India Private Limited is headquartered at Galileo, John F Welch Technology Centre, 122 Epip Zone Phase Ii, Hoodi Village, White, Field Road, Bangalore, Karnataka, 560066.

When was Hyclone Life Sciences Solutions India Private Limited incorporated?

Hyclone Life Sciences Solutions India Private Limited was incorporated on 01 August 2019.

Who are the current directors of Hyclone Life Sciences Solutions India Private Limited?

The current directors of Hyclone Life Sciences Solutions India Private Limited are

What is the primary industry of Hyclone Life Sciences Solutions India Private Limited?

The primary industry of Hyclone Life Sciences Solutions India Private Limited is Professional, Scientific And Technical.

Is Hyclone Life Sciences Solutions India Private Limited a listed company?

Hyclone Life Sciences Solutions India Private Limited is unlisted.

What is the capital structure of Hyclone Life Sciences Solutions India Private Limited?

The authorized capital of Hyclone Life Sciences Solutions India Private Limited is ₹245.00 Cr, and the paid-up capital is ₹235.16 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available